edoc

Items where Author is "Tzankov, A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008
Number of items: 33.

2016

Laubli, H. and Tzankov, A. and Juskevicius, D. and Degen, L. and Rochlitz, C. and Stenner-Liewen, F.. (2016) Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder. Leukemia & Lymphoma, 57 (4). pp. 945-948.

2014

Brault, L. and Rovó, A. and Decker, S. and Dierks, C. and Tzankov, A. and Schwaller, J.. (2014) CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia. Leukemia, 28 (3). pp. 566-576.

2013

Droeser, R. A. and Hirt, C. and Viehl, C. T. and Frey, D. M. and Nebiker, C. and Huber, X. and Zlobec, I. and Eppenberger-Castori, S. and Tzankov, A. and Rosso, R. and Zuber, M. and Muraro, M. G. and Amicarella, F. and Cremonesi, E. and Heberer, M. and Iezzi, G. and Lugli, A. and Terracciano, L. and Sconocchia, G. and Oertli, D. and Spagnoli, G. C. and Tornillo, L.. (2013) Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. European journal of cancer, Vol. 49, H. 9. pp. 2233-2242.

Medinger, M. and Tichelli, A. and Bucher, C. and Halter, J. and Dirnhofer, S. and Rovo, A. and Passweg, J. and Tzankov, A.. (2013) GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM. Bone Marrow Transplantation, 48 (5). pp. 715-721.

2012

Holbro, A. and Jauch, A. and Lardinois, D. and Tzankov, A. and Dirnhofer, S. and Hess, C.. (2012) High prevalence of infections and autoimmunity in patients with thymoma. Human immunology, Vol. 73, H. 3. pp. 287-290.

2011

Läubli, H. and Tzankov, A. and Forno, C. and Rochlitz, C. and Rothschild, S.. (2011) A prostate cancer patient presenting with bilateral subdural hematoma and a subsequent development of multiple skin metastases. Schweizer Krebsbulletin, 2011, H. 4. pp. 354-356.

Daikeler, T. and Tzankov, A. and Hoenger, G. and Gasser, O. and Tyndall, A. and Gratwohl, A. and Hess, C.. (2011) Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation : a clinical case study. Annals of the rheumatic diseases, Vol. 70, H. 7. pp. 1338-1339.

2010

Hoeller, S. and Tzankov, A.. (2010) Consideration of exposure to pharmacological agents helps to avoid diagnostic pitfalls in bone marrow histopathology. memo, Vol. 3, H. 3. pp. 132-135.

Muenst, S. and Hoeller, S. and Willi, N. and Dirnhofera, S. and Tzankov, A.. (2010) Diagnostic and prognostic utility of PD-1 in B cell lymphomas. Disease markers, Vol. 29, H. 1. pp. 47-53.

Tzankov, A. and Dirnhofer, S.. (2010) Nodales Lymphom aus Sicht der Pathologie : den Erfolg der onkologischen Therapie bestimmt der Hausarzt mit. Hausarzt-Praxis, Jg. 5, H. 12. pp. 9-12.

Obermann, E. C. and Müller, N. and Rufle, A. and Menter, T. and Dirnhofer, S. and Tzankov, A.. (2010) [Clonal relationship of Hodgkin lymphoma and its recurrence]. Der Pathologe, Vol. 31, Suppl. 2. pp. 132-133.

2009

Obermann, E. C. and Csato, M. and Dirnhofer, S. and Tzankov, A.. (2009) Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 754-756.

Hoeller, S. and Tzankov, A. and Feichter, G. and Obermann, E. and Dirnhofer, S.. (2009) Analysis of CD20 alone could be misleading in lineage determination of B-cell lymphomas : a case of CD20 negative diffuse large B-cell lymphoma in abdominal effusion. Cytopathology, Vol. 20, no. 4. pp. 273-274.

Obermann, E. C. and Csato, M. and Dirnhofer, S. and Tzankov, A.. (2009) BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 903-907.

Went, P. and Zimpfer, A. and Tzankov, A. and Dirnhofer, S.. (2009) CD5 expression in de novo diffuse large B-cell lymphomas. Annals of oncology, Vol. 20, H. 4. pp. 789-790.

Hauke, D. and Saxer, F. and Tzankov, A. and Valderrabano, V.. (2009) Morbus Still eine seltene Differentialdiagnose in der Orthopädie. Orthopädische Praxis, Vol. 45. pp. 62-66.

Adams, H. and Tzankov, A. and Lugli, A. and Zlobec, I.. (2009) New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 986-997.

2008

Tzankov, A. and Meier, C. and Hirschmann, P. and Went, P. and Pileri, S. A. and Dirnhofer, S.. (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica, Vol. 93, H. 2. pp. 193-200.

Adams, H. and Schmid, P. and Dirnhofer, S. and Tzankov, A.. (2008) Cytokeratin expression in hematological neoplasms : a tissue microarray study on 866 lymphoma and leukemia cases. Pathology, research and practice, Vol. 204. pp. 569-573.

Lugli, A. and Tzankov, A. and Zlobec, I. and Terracciano, L. M.. (2008) Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Modern pathology, Vol. 21, no. 11. pp. 1403-1412.

Fong, D. and Steurer, M. and Obrist, P. and Barbieri, V. and Margreiter, R. and Amberger, A. and Laimer, K. and Gastl, G. and Tzankov, A. and Spizzo, G.. (2008) Ep-CAM expression in pancreatic and ampullary carcinomas : frequency and prognostic relevance. Journal of clinical pathology, Vol. 61. pp. 31-35.

Brunner, A. and Prelog, M. and Verdorfer, I. and Tzankov, A. and Mikuz, G. and Ensinger, C.. (2008) EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder. Journal of clinical pathology, Vol. 61. pp. 307-310.

Schwentner, I. and Witsch-Baumgartner, M. and Sprinzl, G. M. and Krugmann, J. and Tzankov, A. and Jank, S. and Zwierzina, H. and Loeffler-Ragg, J.. (2008) Identification of the rare EGFR mutation p.G796S as somatic and germline mutation in white patients with squamous cell carcinoma of the head and neck. Head & neck, Vol. 30, H. 8. pp. 1040-1044.

Went, P. and Seemayer, C. A. and Pileri, S. and Maurer, R. and Tzankov, A. and Dirnhofer, S.. (2008) Lack of protein expression of the Simian virus 40 large T antigen in human lymphomas. Journal of Medical Virology, Vol. 80, H. 6. pp. 1112-1115.

Brunner, A. and Verdorfer, I. and Prelog, M. and Mayerl, C. and Mikuz, G. and Tzankov, A.. (2008) Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers. Pathobiology, 75 (1). pp. 25-33.

Tzankov, A. and Adams, H. and Sterlacci, W.. (2008) Milzruptur - klinisch-pathologische Zusammenhänge und Diagnostik. Der Pathologe, Vol. 29, H. 2. pp. 148-157.

Fend, F. and Tzankov, A. and Bink, K. and Seidl, S. and Quintanilla-Martinez, L. and Kremer, M. and Dirnhofer, S.. (2008) Modern techniques for the diagnostic evaluation of the trephine bone marrow biopsy : methodological aspects and applications. Progress in histochemistry and cytochemistry, Vol. 42, H. 4. pp. 203-252.

Salvador, C. and Steurer, M. and Tzankov, A. and Wolf, A. M. and Gastl, G. and Konwalinka, G. and Wolf, D.. (2008) Naturally occurring CD4+ CD25+ regulatory T cells modulate the haematopoietic potential of human stem cells in vitro. British journal of haematology, Vol. 142, No. 5. pp. 845-847.

Baumhoer, D. and Tzankov, A. and Dirnhofer, S. and Tornillo, L. and Terracciano, L. M.. (2008) Patterns of liver infiltration in lymphoproliferative disease. Histopathology, Vol. 53, no. 1. pp. 81-90.

Went, P. and Tzankov, A. and Schwaller, J. and Passweg, J. and Roosnek, E. and Huard, B.. (2008) Role of the tumor necrosis factor ligand APRIL in Hodgkin's lymphoma : a retrospective study including 107 cases. Experimental hematology, Vol. 36, H. 5. pp. 533-534.

Tzankov, A. and Sotlar, K. and Muhlematter, D. and Theocharides, A. and Went, P. and Jotterand, M. and Horny, H. P. and Dirnhofer, S.. (2008) Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3. Journal of clinical pathology, Vol. 61. pp. 958-961.

Tzankov, A.. (2008) Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Magazine of European Medical Oncology (MEMO), Vol. 1, H. 3. pp. 161-165.

Tzankov, A. and Adams, H. and Sterlacci, W.. (2008) [Rupture of the spleen. Clinicopathological correlations and diagnostic procedures]. Der Pathologe, Vol. 29, H. 2. pp. 148-157.

This list was generated on Thu Mar 28 15:08:39 2024 CET.